R&D Message

Dear Visitors,

Research and Development is the engine that drives Nivix Pharmaceuticals forward. As Head of R&D, I am proud to lead a team of scientists and technical specialists who are dedicated to developing safe, effective, and clinically relevant pharmaceutical products for the Nepalese market and beyond.

Our R&D philosophy is grounded in scientific rigour and regulatory awareness. Every formulation we develop undergoes a structured process — from feasibility assessment and prototype development to stability studies, bioequivalence evaluation where applicable, and dossier preparation for regulatory submission. We work closely with our quality and production teams to ensure that laboratory-scale success translates seamlessly into commercial manufacturing.

Innovation at Nivix is not limited to new molecules alone. We focus equally on improving existing formulations, optimising delivery systems, and addressing unmet therapeutic needs within our reach. Our laboratory is equipped with modern analytical instruments, and our scientists stay current with international pharmacopoeial standards and evolving regulatory guidelines.

Collaboration is central to our approach. We engage with academic institutions, contract research organisations, and regulatory bodies to strengthen our knowledge base and accelerate product development timelines. We also invest in training our R&D staff continuously, recognising that the quality of our people directly determines the quality of our science.

The pharmaceutical landscape is changing rapidly, and Nivix is committed to staying at the forefront. We will continue to expand our pipeline, pursue opportunities in high-demand therapeutic categories, and uphold the scientific integrity that defines our work. Our ultimate measure of success is simple: medicines that improve patient outcomes and earn the confidence of prescribing physicians.

Thank you for your interest in our research efforts. We look forward to sharing more of our innovations with you in the years to come.

Best regards,
Head of Research & Development
Nivix Pharmaceuticals Limited